Skip to main content

Table 2 Demographic and baseline characteristics of patients receiving treatments that did/did not follow the guidelines

From: The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort study

 

All population

Followed "when-to-start" guidelines

Followed "what-to-start" guidelines

Characteristic

N = 1,365

Yes (n = 1,214)

No (n = 151)

P

Yes (n = 1,215)

No (n = 150)

P

Male (%)

69.7

68.6

78.2

0.02

68.7

77.3

0.03

Median Age (years)

37.3

37.5

34.7

0.002

37.1

38.5

-

MSM (%)

41.4

39.0

60.9

<0.001

41.1

44.0

-

HBV/HCV coinfection (%)

13.1

13.3

11.3

-

13.2

12.7

-

CDC stage C (%)

22.6

25.4

0

<0.001

20.2

41.3

<0.001

Median CD4 (/mm3)

248

230

513

<0.001

256

182

<0.001

Median HIV-RNA (log cps/mL)

4.8

4.8

4.4

<0.001

4.7

4.9

<0.001

HIV-RNA >105 copies/mL (%)

40.5

41.4

14.3

<0.0001

37.3

48.2

<0.0001

  1. Abbreviations: MSM men who have sex with men, HBV hepatitis B virus, HCV hepatitis C virus, CDC Centers for Disease Control and Prevention, HIV human immunodeficiency virus.